<- Go Home

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Market Cap

EUR 1.7B

Volume

1.1M

Cash and Equivalents

EUR 231.3M

EBITDA

EUR 15.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 106.5M

Profit Margin

13.70%

52 Week High

EUR 21.69

52 Week Low

EUR 5.06

Dividend

N/A

Price / Book Value

1.71

Price / Earnings

-9.65

Price / Tangible Book Value

2.46

Enterprise Value

EUR 1.8B

Enterprise Value / EBITDA

69.17

Operating Income

-EUR 60.1M

Return on Equity

-16.25%

Return on Assets

-1.77

Cash and Short Term Investments

EUR 303.3M

Debt

EUR 470.1M

Equity

EUR 968.5M

Revenue

EUR 777.1M

Unlevered FCF

-EUR 181.9M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches